EUVIMEDEUVIMED entdecken
Crossref

Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis

Hayam Ali AlRasheed, Mahmoud S Abdallah, Esraa M Mosalam, Mostafa M Bahaa, Muhammed M Salahuddin, Amir O Hamouda, Sarah Alrubia, Amsha S Alsegiani, Eman El-Khateeb, Mohamed Kh Elmahdy, Nora Elshorbagi, Abd El Razeq A Meselhy und 2 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 13479-13496

DOI: 10.1007/s00210-026-05242-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 27.03.2026. Verfasst von Hayam Ali AlRasheed und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Thiazoles, Colitis, Ulcerative, Atorvastatin, TOR Serine-Threonine Kinases. Die Arbeit nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The exact etiology of ulcerative colitis (UC) remains incompletely understood. However, substantial evidence implicates multiple signaling pathways in its pathogenesis, including interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3), wingless/Int1 (Wnt), heme oxygenase-1 (HO-1), nuclear factor erythroid 2-related factor 2 (Nrf2), adenosine monophosphate-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), and NLR family pyrin domain-containing 3 (NLRP3). Atorvastatin and nitazoxanide have demonstrated anti-inflammatory, antioxidant, and immunomodulatory properties that may target these signaling pathways. The aim of this study was to investigate the coloprotective effects of atorvastatin and nitazoxanide in an experimental model of UC. Colitis was induced by intracolonic administration of acetic acid (AA) in rats. A total of 32 rats were randomly assigned to four groups (n = 8 each): normal control, colitis, atorvastatin-treated, and nitazoxanide-treated groups. Disease severity was assessed via colon length, weight, disease activity index, and histopathological evaluation. Tissue levels of SIRT1, mTOR, HO-1, Nrf2, STAT3, AMPK, and Dickkopf-related protein 1 (DKK1) were measured, along with colonic gene expression of NLRP3, Wnt, IL-6, TNF-α, and DKK1. Additionally, TNF-α and IL-6 protein expressions were assessed by immunohistochemistry. Intracolonic AA administration caused significant biochemical, inflammatory, and structural damage to the colon. Both atorvastatin and nitazoxanide significantly attenuated colitis, as evidenced by reduced disease activity scores, histological improvement, and decreased expression of colonic mTOR, NLRP3, DKK1, IL-6, TNF-α, and STAT3. Conversely, both agents upregulated HO-1, Nrf2, SIRT1, Wnt, and AMPK levels. Histologically, treated groups exhibited partial restoration of normal mucosal architecture, with fewer irregular crypts and reduced lymphoplasmacytic infiltration. Atorvastatin and nitazoxanide ameliorated experimental colitis through modulation of inflammatory and oxidative stress pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolesColitis, UlcerativeAtorvastatinTOR Serine-Threonine KinasesAnti-Inflammatory AgentsAnimalsMaleSignal TransductionNF-E2-Related Factor 2Nitro CompoundsNLR Family, Pyrin Domain-Containing 3 ProteinDisease Models, AnimalAcetic AcidColonHeme Oxygenase (Decyclizing)RatsRats, Sprague-DawleyRats, Wistar

Stichwörter der Autor:innen

AtorvastatinIL-6/STAT3/WntMTOR/NLRP3NitazoxanideNrf2Ulcerative colitis

Substanzen

ThiazolesAtorvastatinnitazoxanideNF-E2-Related Factor 2Nitro CompoundsTOR Serine-Threonine KinasesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratHmox1 protein, ratNfe2l2 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
  • Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, Jordan.
  • Biochemistry Department, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, 32511, Menoufia, Egypt.
  • Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt. mostafabahaamnf@gmail.com.
  • Pharmacy Practice Department, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt. mostafabahaamnf@gmail.com.
  • Pharmacy Practice Department, Faculty of Pharmacy, East Port Said National University, Port Said, Egypt. mostafabahaamnf@gmail.com.

Zitieren

APA

AlRasheed, H. A., Abdallah, M. S., Mosalam, E. M., Bahaa, M. M., Salahuddin, M. M., Hamouda, A. O., Alrubia, S., Alsegiani, A. S., El-Khateeb, E., Elmahdy, M. K., Elshorbagi, N., Meselhy, A. E. R. A., Hamza, E., & Wahsh, E. (2026). Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 13479-13496. https://doi.org/10.1007/s00210-026-05242-8

Vancouver

AlRasheed HA, Abdallah MS, Mosalam EM, Bahaa MM, Salahuddin MM, Hamouda AO, et al. Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):13479-13496. doi:10.1007/s00210-026-05242-8

BibTeX
@article{AlRasheed2026,
  author = {AlRasheed, Hayam Ali and Abdallah, Mahmoud S and Mosalam, Esraa M and Bahaa, Mostafa M and Salahuddin, Muhammed M and Hamouda, Amir O and Alrubia, Sarah and Alsegiani, Amsha S and El-Khateeb, Eman and Elmahdy, Mohamed Kh and Elshorbagi, Nora and Meselhy, Abd El Razeq A and Hamza, Eman and Wahsh, Eman},
  title = {Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {9},
  pages = {13479--13496},
  doi = {10.1007/s00210-026-05242-8}
}
Kostenlos starten →